Fluxion Biosciences
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
801 Capitola Dr Ste 10, Durham, North Ca...Website
www.fluxionbio.comRevenue
<$5 MillionIndustry
About Fluxion Biosciences
Fluxion Biosciences Org Chart
Is Fluxion Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Fluxion Biosciences has new funding data
Website visits: Recent activity has been detected on your website
Check if Fluxion Biosciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Fluxion Biosciences launches new products
Congratulate Masked Content for being promoted to Masked Content at Fluxion Biosciences
Fluxion Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Fluxion Biosciences is spiking on competitors!
Click to see if Fluxion Biosciences had a recent Job posting/layoffs
Earning: See what the market has to say on Fluxion Biosciences recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Fluxion Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to Fluxion Biosciences
Compare insights from companies similar to Fluxion Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fluxion Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Fluxion Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Fluxion Biosciences.
Fluxion Biosciences financials insights
Gather financial insights about Fluxion Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$7M
Series A
$7M
Series C
$12M
Unspecified
$2M
Debt
$150K
Debt
$228K
Fluxion Biosciences Tech Stack
A closer look at the technologies used by Fluxion Biosciences
Most Recent Scoops
Fluxion Biosciences News & Media
Cell Microsystems Acquires Fluxion Biosciences; Announces Series B Financing
The Durham, North Carolina-based cell biology tech firm said the acquisition was supported by a concurrent Series B financing led by Telegraph Hill Partners.Fluxion Biosciences Introduces a Complete System for Lead-to-Answer Screening in Ion Channel Assays
ALAMEDA, Calif., Sept. 20, 2022 /PRNewswire/ -- Fluxion Biosciences, a global leader in automated patch clamp systems for ion channel drug discovery, today announced the release of an integrated and affordable solution for simplifying automated ion channel assays. Ion channels are the...Fluxion Launches Three New Spotlightâ„¢ Liquid Biopsy NGS Panels
ALAMEDA, Calif., Dec. 13, 2019 /PRNewswire/ -- Fluxion Biosciences announces the launch of three new targeted NGS liquid biopsy panels: Spotlight Myeloid, Spotlight EGFR, and Spotlight TP53. These new panels complement Fluxion's current pan-cancer panel, Spotlight 59, and have been...Fluxion Biosciences Receives NIH Grant for Development of Advanced Non-Invasive Prenatal Test
ALAMEDA, Calif., Oct. 3, 2019 /PRNewswire/ -- Fluxion Biosciences, a leading developer of precision solutions for life science research and diagnostics, today announced that it has received a National Institutes of Health grant for development of its novel Spotlightâ„¢ NIPT non-invasive...
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fluxion Biosciences
Cell Microsystems specializes in innovative tools that enable researchers to image, sort, and isolate single cells and colonies, particularly in areas like CRISPR gene editing, cancer research, and stem cell biology. Their product line includes advanced systems for cell culture analysis, microbiology, and automated cell counting. The company serves... Read More